Both trials indicated lasting visual improvements in patients treated with Ixo-vec who had previously received anti-VEGF injections.
Sean Adrean, MD
Advertisement
Dr. Adrean is a specialist in age-related macular degeneration at Retina Consultants of Orange County.
Articles by Sean Adrean, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5